What happened
U.S. overdose deaths declined in 2023 for the first time in five years, according to preliminary data released Wednesday by the Centers for Disease Control and Prevention (CDC). But last year's 107,543 fatal overdoses, while a 3% drop, marked the third straight year of more than 100,000 deaths.
Who said what
The "progress over the last 12 months should make us want to reinvigorate our efforts" to reduce drug-related deaths, said CDC chief medical officer Deb Houry. The "leveling of the overdose curve" is welcome but the death toll remained "historically high" and not enough people are being treated for their addictions, said Dr. Brian Hurley at the American Society of Addiction Medicine.
The report "did not offer reasons for the drop," led by a 3.7% dip in deaths from fentanyl and other synthetic opioids, The New York Times said. "But naloxone, a drug that reverses opioid overdoses, has become more widely available," as have test strips to detect fentanyl.
What next?
The final 2023 overdose numbers will be released in several months, after more state data comes in.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Nigel Farage: was he a teenage racist?Talking Point Farage’s denials have been ‘slippery’, but should claims from Reform leader’s schooldays be on the news agenda?
-
Pushing for peace: is Trump appeasing Moscow?In Depth European leaders succeeded in bringing themselves in from the cold and softening Moscow’s terms, but Kyiv still faces an unenviable choice
-
Sudoku medium: November 29, 2025The daily medium sudoku puzzle from The Week
-
Vaccine critic quietly named CDC’s No. 2 officialSpeed Read Dr. Ralph Abraham joins another prominent vaccine critic, HHS Secretary Robert F. Kennedy Jr.
-
Nitazene is quietly increasing opioid deathsThe explainer The drug is usually consumed accidentally
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
The UK’s opioid crisis: why the stats don’t add upThe Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
-
Why the FDA wants to restrict kratom-related productsIn the Spotlight The compound is currently sold across the United States
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
